Lantern Pharma (@LanternPharma) / X

Lantern Pharma

665 posts

Lantern Pharma

@LanternPharma

Leveraging A.I. to develop, revitalize, & rescue drugs for oncology. (Nasdaq : LTRN)

DALLAS & PLANO, TEXAS - USA

lanternpharma.com

Joined June 2015

Lantern Pharma
@LanternPharma
Aug 3
Lantern has established Open-Medicine AI (OMAI), a standalone company created to commercialize and expand the agentic AI co-scientist platform withZeta.ai. Built for real-world drug development. Positioned to scale beyond oncology. 🔗bit.ly/3RPErpL $LTRN
Lantern Pharma
@LanternPharma
Jun 22
Join Lantern Pharma during #BIO2026 for an executive roundtable hosted by @Polsinelli . Featuring CEO Panna Sharma, Moderated by Matt Murer 📅 June 23 🕗 8:00–10:00 AM PT RSVP NOW: bit.ly/4uFxDsi $LTRN
Lantern Pharma
@LanternPharma
Jun 2
New HARMONIC™ data continue to strengthen the LP-300 story in EGFR exon 21 L858R never-smoker NSCLC: 📈 8.9-month mPFS 📈 77% CBR The updated dataset is supporting partnering discussions at #ASCO26. Full release: bit.ly/4ejc4st $LTRN
Lantern Pharma
@LanternPharma
May 20
🫁 Join us TOMORROW, May 21, at 3 PM ET for a webinar on never-smoker NSCLC and the HARMONIC™ trial featuring Joseph Treat, M.D. Discussion follows $LTRN’s recent FDA Type C outcome supporting key Phase 2 amendments for LP-300. Register NOW bit.ly/HarmonicTrial
Lantern Pharma
@LanternPharma
May 7
$LTRN unveils the next roadmap for withZeta.ai: → ZetaSwarm™: multi-agent scientific reasoning → ZetaOmics™: real-time computational biology Advancing toward an AI co-scientist for oncology R&D Learn more: bit.ly/4weTdpt @withzeta